Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

AMGN

AMGEN Inc.

Oct 04 • 04:00PM ET

319.66

Dollar change +2.18
Percentage change 0.69	%

Healthcare • Drug Manufacturers - General • USA • NASD

Held by: VTI VOO QQQ SCHD SPY IVV DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	55.07	EPS (ttm)	5.80	Insider Own	0.26%	Shs Outstand	537.33M	Perf Week	-0.93%
Market Cap	171.76B	Forward P/E	15.29	EPS next Y	20.90	Insider Trans	-0.15%	Shs Float	535.94M	Perf Month	-1.45%
Income	3.13B	PEG	13.71	EPS next Q	5.13	Inst Own	78.26%	Short Float	1.68%	Perf Quarter	2.63%
Sales	30.74B	P/S	5.59	EPS this Y	4.72%	Inst Trans	0.67%	Short Ratio	4.53	Perf Half Y	18.41%
Book/sh	11.03	P/B	28.98	EPS next Y	7.02%	ROA	3.46%	Short Interest	9.00M	Perf Year	20.43%
Cash/sh	17.31	P/C	18.47	EPS next 5Y	4.02%	ROE	49.27%	52W Range	249.70 - 346.85	Perf YTD	10.99%
Dividend Est.	9.18 (2.87%)	P/FCF	31.34	EPS past 5Y	-0.22%	ROI	4.96%	52W High	-7.84%	Beta	0.60
Dividend TTM	8.88 (2.78%)	Quick Ratio	0.89	Sales past 5Y	3.42%	Gross Margin	63.06%	52W Low	28.02%	ATR (14)	6.43
Dividend Ex-Date	Aug 16, 2024	Current Ratio	1.26	EPS Y/Y TTM	-60.83%	Oper. Margin	21.13%	RSI (14)	43.04	Volatility	1.44% 2.01%
Employees	26700	Debt/Eq	10.57	Sales Y/Y TTM	16.68%	Profit Margin	10.18%	Recom	2.16	Target Price	329.59
Option/Short	Yes / Yes	LT Debt/Eq	9.64	EPS Q/Q	-46.30%	Payout	68.24%	Rel Volume	0.74	Prev Close	317.48
Sales Surprise	0.43%	EPS Surprise	-0.29%	Sales Q/Q	19.90%	Earnings	Aug 06 AMC	Avg Volume	1.99M	Price	319.66
SMA20	-2.29%	SMA50	-2.42%	SMA200	5.17%	Trades		Volume	1,465,705	Change	0.69%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320
Apr-24-23	Reiterated	Oppenheimer	Outperform	$292 → $290
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $265
Feb-13-23	Reiterated	Truist	Buy	$280 → $260
Nov-18-22	Initiated	Credit Suisse	Underperform	$240
Oct-31-22	Downgrade	Barclays	Equal Weight → Underweight	$234

Show Previous Ratings

Today 05:50AM	3 Magnificent Dividend Stocks to Buy in October (Motley Fool)
Oct-05-24 09:05AM	Amgen Inc. (AMGN): A Buzzing AI Health Stock to Add to Your Portfolio (Insider Monkey)
06:30AM	Should You Buy the Dip on This Top Growth Stock? (Motley Fool)
Oct-04-24 05:50PM	Amgen (AMGN) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Oct-03-24 06:00PM	Why Amgen (AMGN) Dipped More Than Broader Market Today (Zacks)
10:05AM	Loading…
10:05AM	Amgen (AMGN) Rose Owing To The Announcement Of Promising Data For Its Novel Medication (Insider Monkey)
08:30AM	Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. (Investor's Business Daily)
Oct-02-24 05:00AM	Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now (Quartz)
Oct-01-24 10:53AM	Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi (Pharmaceutical Technology)
09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
09:00AM	LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE (PR Newswire)
Sep-30-24 05:12PM	Amgen must face lawsuit claiming it hid $10.7 billion tax bill (Reuters)
10:30AM	NASDAQ: AMGN Lawsuit Notice: Investors in shares of Amgen Inc. (NASDAQ: AMGN) should contact the Shareholders Foundation (PR Newswire)
05:02AM	Amgen Inc. (AMGN): Hedge Fund Interest and Strong Pipeline Support Moderate Buy Rating (Insider Monkey)
Sep-28-24 07:40AM	Amgen initiated with an Overweight at Cantor Fitzgerald (TipRanks)
05:50PM	Loading…
Sep-27-24 05:50PM	Amgen (AMGN) Ascends While Market Falls: Some Facts to Note (Zacks)
04:39PM	Regeneron Shares Head for Worst Month Since 2019 on Legal Ruling (Bloomberg)
02:19PM	Calls of the Day: Salesforce, Walmart, Pepsico and Amgen (CNBC TV)
06:13AM	Amgen Inc. (AMGN): An Undervalued Wide Moat Stock to Buy According to Analysts (Insider Monkey)
Sep-25-24 05:07PM	S&P 500 Gains and Losses Today: Carmakers Lose Ground as Analyst Cites Challenges (Investopedia) -5.46%
04:15PM	Amgen stock falls on lackluster drug data (Yahoo Finance Video)
04:05PM	Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases (Investor's Business Daily)
01:30PM	Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs (Benzinga)
12:54PM	Amgen Stock Falls on Disappointing Drug Data (The Wall Street Journal)
08:04AM	Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market (Benzinga)
07:36AM	Amgen's TEPEZZA gets Japan's MHLW approval for thyroid eye disease treatment (Pharmaceutical Business Review)
07:13AM	Amgen claims success for two immune drugs, but results underwhelm Wall Street (BioPharma Dive)
05:29AM	Amgen reports first phase 3 win for $400M eczema drug but Dupixent rivalry doubts remain (FierceBiotech.com)
Sep-24-24 05:13PM	S&P 500 Gains and Losses Today: Economic Stimulus Boosts China-Facing Stocks (Investopedia)
04:00PM	TEPEZZA (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE (PR Newswire)
01:33PM	Loading…
01:33PM	Top Stock Movers Now: Nvidia, Freeport-McMoRan, Visa, and More (Investopedia)
04:57AM	2 Weight Loss Stocks That Could Rocket Higher This Year (Motley Fool)
Sep-23-24 06:00PM	Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors (Zacks)
05:30PM	S&P 500 Gains and Losses Today: Tesla Stock Jumps as Analysts Highlight Catalysts (Investopedia)
04:13PM	Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea (Investor's Business Daily)
04:00PM	AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE (PR Newswire)
08:01AM	Unlocking Intrinsic Value: Analysis of Amgen Inc (GuruFocus.com)
07:30AM	Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy? (Motley Fool)
Sep-20-24 07:45AM	Where Will Amgen Be in 5 Years? (Motley Fool)
Sep-17-24 05:50PM	Amgen (AMGN) Stock Dips While Market Gains: Key Facts (Zacks)
12:40PM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
09:00AM	Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know (Zacks)
Sep-16-24 06:00PM	Amgen (AMGN) Rises Higher Than Market: Key Facts (Zacks)
06:00AM	This 'forgotten child' is one of the best biotech plays: Analyst (Yahoo Finance Video)
Sep-13-24 10:00AM	2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500 (Motley Fool)
09:00AM	AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024 (PR Newswire)
Sep-12-24 06:00AM	Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now (Motley Fool)
Sep-11-24 06:32AM	Viridian Therapeutics stock jumps after Phase III trial met all endpoints (Clinical Trials Arena)
Sep-10-24 05:50PM	Why Amgen (AMGN) Outpaced the Stock Market Today (Zacks)
04:38PM	How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition (Investor's Business Daily)
09:36AM	Viridian Spikes On A 'Bull-Case Scenario' For Eye Drug Considered Amgen Rival (Investor's Business Daily)
Sep-09-24 09:00AM	AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024 (PR Newswire)
08:00AM	Amgen Inc: An Exploration into Its Intrinsic Value (GuruFocus.com)
Sep-08-24 01:54AM	Amgen Inc. (AMGN): Why Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
Sep-06-24 09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
Sep-05-24 11:31AM	Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-04-24 05:50PM	Why the Market Dipped But Amgen (AMGN) Gained Today (Zacks)
Sep-03-24 09:17AM	Moderna, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
12:00AM	Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring (Barrons.com)
Aug-30-24 04:00PM	AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE (PR Newswire)
11:12AM	The 10 Pharma Stocks To Watch Including Viking, Roche And Amgen Amid The Fast-Growing Obesity Drug Race (Investor's Business Daily)
Aug-29-24 04:00PM	AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
01:19PM	The 9 Pharma Stocks To Watch Including Viking, Roche And Amgen Amid The Fast-Growing Obesity Drug Race (Investor's Business Daily)
Aug-28-24 02:04PM	Final Trades: Intuit, Amgen, the INDY and URNM (CNBC TV)
Aug-26-24 09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:00AM	Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value (GuruFocus.com)
Aug-25-24 06:30PM	3 Unstoppable Dividend Stocks to Buy Right Now (Motley Fool)
Aug-21-24 03:14PM	Pathalys secures $105m to advance SHPT drug through approval (Pharmaceutical Technology)
04:32AM	Amgens Otezla launched for paediatric plaque psoriasis in US (Pharmaceutical Technology)
Aug-20-24 09:00AM	OTEZLA (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE TO SEVERE PEDIATRIC PLAQUE PSORIASIS (PR Newswire)
01:27AM	10 Unhealthiest Countries in Asia (Insider Monkey)
Aug-18-24 05:25AM	2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade (Motley Fool)
Aug-17-24 06:20AM	This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline (Motley Fool)
Aug-15-24 05:30PM	These 10 drugs will be cheaper after Medicare negotiations (Yahoo Finance Video)
04:20PM	US Drug Price Measure to Cut Costs by $7.5 Billion in 2026 (Bloomberg)
10:49AM	Big Pharma: The government revealed its list of negotiated drug prices. Here are the reactions. (Yahoo Finance)
07:49AM	Medicare to save $6B in 2026 from the first ever Part D drug pricing negotiations (Yahoo Finance)
Aug-14-24 10:31AM	Amgen Inc. (AMGN): Pioneering Healthcare Innovations in Obesity Treatment (Insider Monkey)
Aug-13-24 09:00AM	Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-12-24 08:00AM	Navigating Market Uncertainty: Intrinsic Value of Amgen Inc (GuruFocus.com)
Aug-11-24 08:09AM	What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales (Yahoo Finance)
Aug-10-24 08:18AM	CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-09-24 03:33PM	MSD sets sights on bispecific antibody market with Curon acqusition (Pharmaceutical Technology)
01:00PM	How To Earn $100 Per Month From Amgen Stock (Benzinga)
11:55AM	Biotech giant Amgen announces new office in tech-savvy Hyderabad (Investment Monitor)
Aug-08-24 08:43PM	Are Hedge Funds Bullish on Amgen Inc. (AMGN) Now? (Insider Monkey)
Aug-07-24 06:57PM	Amgen Stock Slides on Lowered Guidance (Investopedia) -5.00%
04:10PM	Why Biotech Giant Amgen Stands A Chance Of Taking On Novo, Lilly In Obesity (Investor's Business Daily)
01:52PM	Analyst Report: Amgen Inc. (Morningstar Research)
01:11PM	Why Amgen Stock Is Down Today Despite Solid Q2 Results (Motley Fool)
12:32PM	Midday movers: Super Micro Computer, Airbnb and Lyft fall; Shopify rises (Investing.com)
12:06PM	Amgen, Airbnb fall; Fortinet, Dynatrace rise, Wednesday, 8/7/2024 (Associated Press)
10:22AM	Heard on the Street: It Isnt Time for Novo Nordisk to Worry About Wegovy Yet (The Wall Street Journal)
10:06AM	Amgen Faces Near-Term Challenges But Long-Term Growth Prospects Remain Strong: Analyst (Benzinga)
09:55AM	Amgen (AMGN) Stock Down Despite Q2 Earnings & Sales Beat (Zacks)
09:49AM	Stocks to Watch Wednesday: Super Micro, Disney, Rivian, Lyft (The Wall Street Journal)
06:32AM	Amgen reports 45.9% decline in net income to $746m in Q2 2024 (Pharmaceutical Technology)
Aug-06-24 06:45PM	Amgen 'confident' in weight-loss drug MariTide: CFO (Yahoo Finance Video)
06:00PM	Amgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:31PM	Amgen will continue to see growth regardless of a recession: CFO (Yahoo Finance Video)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	May 03 '24	Sale	313.09	2,117	662,802	9,883	May 03 07:48 PM
Grygiel Nancy A.	SVP & CCO	Dec 04 '23	Sale	273.03	2,096	572,276	10,874	Dec 04 07:41 PM
Graham Jonathan P	EVP, Gen. Counsel & Secy.	Nov 08 '23	Sale	272.81	10,000	2,728,136	28,078	Nov 13 08:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc.

Upgrade your FINVIZ experience